BioCentury
ARTICLE | Distillery Therapeutics

Neurology

July 31, 2017 7:20 PM UTC

Cell culture studies suggest inhibiting DISC1-FBXW7 binding could help treat schizophrenia and major depressive disorder (MDD). In human neuroprogenitor cells (NPCs) differentiated from induced plurip...